Objectif Osteoporosis constitutes a major public health concern. The economic burden of osteoporotic fractures in EU is expected to increase 25% by 2025 compared to 2010. These estimates may indicate an inefficiency of current drugs for osteoporosis. Actually, the use of pharmacological agents for osteoporosis has been decreasing in EU, probably due to the reported side effects. Therefore, there is a need for innovative agents to reduce the burden of osteoporosis. Colostrum is a promising agent against bone loss since it has natural constituents that are directly involved in bone metabolism. As a nutraceutical, colostrum confers an advantage over pharmacological drugs since it can avoid side effects. However, the possibility of its use as a nutraceutical agent for osteoporosis have only received attention within the scientific community. The knowledge produced on the effects of colostrum on bone metabolism has not yet been transferred to the market because academic institutions lack on expertise to create a new product. On the other hand, industry has knowledge on product development, but lack expertise on research skills. In accordance, what hinders the creation of an innovative product based on colostrum for prevention of osteoporosis is the absence of an intersectorial collaboration. As consequence, there is a clearly gap between research on the matter and its application. COLOSTEO aims to fill in this gap by creating an intersectorial collaboration to exchange knowledge and expertise towards the creation of an innovative nutraceutical product based on colostrum to prevent osteoporosis. This aim will be achieved by bridging two academic with two industrial institutions that through intersectorial secondments will exchange knowledge, ideas and expertise towards the creation of an innovative nutraceutical product based on colostrum to prevent osteoporosis. Champ scientifique medical and health scienceshealth sciencespublic health Programme(s) H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme H2020-EU.1.3.3. - Stimulating innovation by means of cross-fertilisation of knowledge Thème(s) MSCA-RISE-2017 - Research and Innovation Staff Exchange Appel à propositions H2020-MSCA-RISE-2017 Voir d’autres projets de cet appel Régime de financement MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) Coordinateur PANEPISTIMIO THESSALIAS Contribution nette de l'UE € 207 000,00 Adresse ARGONAFTON FILELLINON 38221 Volos Grèce Voir sur la carte Région Κεντρική Ελλάδα Θεσσαλία Μαγνησία Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 207 000,00 Participants (4) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire UNIVERSIDADE DO PORTO Portugal Contribution nette de l'UE € 207 000,00 Adresse PRACA GOMES TEIXEIRA 4099-002 Porto Voir sur la carte Région Continente Norte Área Metropolitana do Porto Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 207 000,00 CENTRO DE ESTUDIOS SUPERIORES DE LA INDUSTRIA FARMACEUTICA SA Participation terminée Espagne Contribution nette de l'UE € 0,00 Adresse CALLE DEL GENERAL ALVAREZ DE CASTRO 41 28020 MADRID Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Comunidad de Madrid Comunidad de Madrid Madrid Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total Aucune donnée CHRISTOS PAPADOPOULOS & SIA OE Grèce Contribution nette de l'UE € 207 000,00 Adresse KITROUS EPISKOPOU 71 431 00 KARDITSA Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Κεντρική Ελλάδα Θεσσαλία Καρδίτσα Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 207 000,00 SALURIS NETWORK SL Espagne Contribution nette de l'UE € 207 000,00 Adresse CALLE ARROYO FONTARRON 53 28030 MADRID Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Comunidad de Madrid Comunidad de Madrid Madrid Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 207 000,00
